Urothelial carcinoma of the urinary bladder (incl. renal pelvis, ureter)
other systemic therapies
The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC).
Efficacy and safety of sacituzumab in metastatic or locally advanced unresectable urothelial carcinoma
